DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - Q2 2013 holdings

$2.12 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 114 reported holdings in Q2 2013. The portfolio turnover from Q1 2013 to Q2 2013 was - .

 Value Shares↓ Weighting
NewDENDREON CORPnote 2.875% 1/1$84,440,000114,140,000
+100.0%
3.98%
AUXL NewAUXILIUM PHARMACEUTICALS INC$80,671,0004,850,644
+100.0%
3.80%
CBST NewCUBIST PHARMACEUTICALS INCcall$72,435,0001,500,000
+100.0%
3.41%
NewEXELIXIS INCnote 4.250% 8/1$65,448,00067,000,000
+100.0%
3.08%
NewNUVASIVE INCnote 2.750% 7/0$61,050,00061,136,000
+100.0%
2.88%
NXTM NewNXSTAGE MEDICAL INC$55,834,0003,909,914
+100.0%
2.63%
PFE NewPFIZER INC$51,959,0001,855,000
+100.0%
2.45%
ARRY NewARRAY BIOPHARMA INC$49,420,00010,885,406
+100.0%
2.33%
TEVA NewTEVA PHARMACEUTICAL INDS LTDadr$48,716,0001,242,759
+100.0%
2.30%
NewHOLOGIC INCdebt 2.000% 3/0$47,567,00047,516,000
+100.0%
2.24%
NewVOLCANO CORPORATIONnote 1.750%12/0$46,129,00050,000,000
+100.0%
2.17%
AZN NewASTRAZENECA PLCsponsored adr$43,894,000928,000
+100.0%
2.07%
KERX NewKERYX BIOPHARMACEUTICALS INC$43,809,0005,864,612
+100.0%
2.06%
OPTR NewOPTIMER PHARMACEUTICALS INC$43,784,0003,025,829
+100.0%
2.06%
SGNT NewSAGENT PHARMACEUTICALS INC$43,684,0002,082,167
+100.0%
2.06%
NewINTEGRA LIFESCIENCES HLDGS Cnote 1.625%12/1$40,589,00041,523,000
+100.0%
1.91%
ATRS NewANTARES PHARMA INC$39,104,0009,400,000
+100.0%
1.84%
FRX NewFOREST LABS INC$38,745,000945,000
+100.0%
1.83%
INFI NewINFINITY PHARMACEUTICALS INC$38,132,0002,354,963
+100.0%
1.80%
NewINTERMUNE INCnote 2.500% 9/1$34,061,00041,570,000
+100.0%
1.60%
NKTR NewNEKTAR THERAPEUTICS$33,954,0002,939,741
+100.0%
1.60%
CBST NewCUBIST PHARMACEUTICALS INC$33,562,000695,000
+100.0%
1.58%
CAH NewCARDINAL HEALTH INC$33,040,000700,000
+100.0%
1.56%
AGN NewALLERGAN INC$31,615,000375,300
+100.0%
1.49%
ANGO NewANGIODYNAMICS INC$29,909,0002,651,466
+100.0%
1.41%
CYH NewCOMMUNITY HEALTH SYS INC NEW$29,821,000636,124
+100.0%
1.41%
NewBROOKDALE SR LIVING INCnote 2.750% 6/1$29,466,00025,000,000
+100.0%
1.39%
AIRM NewAIR METHODS CORP$29,425,000869,025
+100.0%
1.39%
TRNX NewTORNIER N V$28,811,0001,646,318
+100.0%
1.36%
UAM NewUNIVERSAL AMERN CORP NEW$27,248,0003,065,003
+100.0%
1.28%
CTRX NewCATAMARAN CORPcall$26,818,000550,000
+100.0%
1.26%
MRK NewMERCK & CO INC NEW$26,709,000575,000
+100.0%
1.26%
FLML NewFLAMEL TECHNOLOGIES SAsponsored adr$26,599,0004,333,475
+100.0%
1.25%
ABBV NewABBVIE INC$25,507,000617,000
+100.0%
1.20%
AGN NewALLERGAN INCcall$25,272,000300,000
+100.0%
1.19%
STJ NewST JUDE MED INC$23,956,000525,000
+100.0%
1.13%
AET NewAETNA INC NEW$22,239,000350,000
+100.0%
1.05%
ARIA NewARIAD PHARMACEUTICALS INC$22,127,0001,265,104
+100.0%
1.04%
NewARRAY BIOPHARMA INCnote 3.000% 6/0$21,778,00023,000,000
+100.0%
1.03%
ALNY NewALNYLAM PHARMACEUTICALS INC$21,514,000694,000
+100.0%
1.01%
HTWR NewHEARTWARE INTL INC$21,416,000225,167
+100.0%
1.01%
MOH NewMOLINA HEALTHCARE INC$21,193,000570,000
+100.0%
1.00%
CYTK NewCYTOKINETICS INC$20,590,0001,779,622
+100.0%
0.97%
CLVS NewCLOVIS ONCOLOGY INC$20,497,000306,018
+100.0%
0.97%
NewACCURAY INCnote 3.750% 8/0$20,326,00021,200,000
+100.0%
0.96%
XNPT NewXENOPORT INC$20,147,0004,070,090
+100.0%
0.95%
HCA NewHCA HOLDINGS INC$19,942,000553,020
+100.0%
0.94%
ARNA NewARENA PHARMACEUTICALS INC$19,778,0002,568,588
+100.0%
0.93%
ACAD NewACADIA PHARMACEUTICALS INC$19,368,0001,067,115
+100.0%
0.91%
THC NewTENET HEALTHCARE CORP$18,814,000408,120
+100.0%
0.89%
PCYC NewPHARMACYCLICS INC$18,042,000227,030
+100.0%
0.85%
HUM NewHUMANA INC$15,863,000188,000
+100.0%
0.75%
BMRN NewBIOMARIN PHARMACEUTICAL INC$13,768,000247,000
+100.0%
0.65%
NewDENDREON CORPnote 4.750% 6/1$13,611,00013,740,000
+100.0%
0.64%
EW NewEDWARDS LIFESCIENCES CORPcall$13,440,000200,000
+100.0%
0.63%
ACHN NewACHILLION PHARMACEUTICALS IN$13,332,0001,629,833
+100.0%
0.63%
PTLA NewPORTOLA PHARMACEUTICALS INC$12,958,000527,410
+100.0%
0.61%
CEMP NewCEMPRA INC$12,483,0001,606,510
+100.0%
0.59%
PACB NewPACIFIC BIOSCIENCES CALIF IN$12,357,0004,884,368
+100.0%
0.58%
BDSI NewBIODELIVERY SCIENCES INTL IN$10,627,0002,617,586
+100.0%
0.50%
DNDNQ NewDENDREON CORPput$10,300,0002,500,000
+100.0%
0.48%
IART NewINTEGRA LIFESCIENCES HLDGS C$9,452,000258,044
+100.0%
0.45%
SGEN NewSEATTLE GENETICS INCput$9,438,000300,000
+100.0%
0.44%
RIGL NewRIGEL PHARMACEUTICALS INC$9,052,0002,710,053
+100.0%
0.43%
DEPO NewDEPOMED INC$8,458,0001,505,000
+100.0%
0.40%
CCRN NewCROSS CTRY HEALTHCARE INC$8,164,0001,582,227
+100.0%
0.38%
ARAY NewACCURAY INC$8,151,0001,420,000
+100.0%
0.38%
NewINTERMUNE INCnote 2.500%12/1$8,025,0007,500,000
+100.0%
0.38%
MDRX NewALLSCRIPTS HEALTHCARE SOLUTN$8,015,000619,360
+100.0%
0.38%
LPDX NewLIPOSCIENCE INC$7,708,0001,102,744
+100.0%
0.36%
OVAS NewOVASCIENCE INC$7,628,000555,555
+100.0%
0.36%
ATEC NewALPHATEC HOLDINGS INC$7,529,0003,672,604
+100.0%
0.36%
INSM NewINSMED INC$6,623,000553,793
+100.0%
0.31%
ZGNX NewZOGENIX INC$6,581,0003,848,572
+100.0%
0.31%
ANTH NewANTHERA PHARMACEUTICALS INC$6,434,00013,893,465
+100.0%
0.30%
NewACCURAY INCnote 3.500% 2/0$6,256,0005,000,000
+100.0%
0.30%
ATRC NewATRICURE INC$5,985,000630,000
+100.0%
0.28%
MEIP NewMEI PHARMA INC$5,862,000822,199
+100.0%
0.28%
NewALERE INCnote 3.000% 5/1$5,710,0005,750,000
+100.0%
0.27%
DRTX NewDURATA THERAPEUTICS INC$5,418,000752,539
+100.0%
0.26%
XOMA NewXOMA CORP DEL$4,356,0001,200,000
+100.0%
0.20%
FRX NewFOREST LABS INCcall$4,100,000100,000
+100.0%
0.19%
VCRA NewVOCERA COMMUNICATIONS INC$4,026,000273,858
+100.0%
0.19%
TTPH NewTETRAPHASE PHARMACEUTICALS I$3,901,000554,898
+100.0%
0.18%
NewMANNKIND CORPnote 5.750% 8/1$2,725,0002,500,000
+100.0%
0.13%
AMED NewAMEDISYS INC$2,704,000233,066
+100.0%
0.13%
LCAV NewLCA-VISION INC$2,509,000830,856
+100.0%
0.12%
MRGE NewMERGE HEALTHCARE INC$2,479,000688,510
+100.0%
0.12%
DYAX NewDYAX CORP$2,352,000679,866
+100.0%
0.11%
ELN NewELAN PLCadr$2,334,000165,084
+100.0%
0.11%
DSCO NewDISCOVERY LABORATORIES INC N$2,026,0001,333,000
+100.0%
0.10%
NewMANNKIND CORPnote 3.750%12/1$2,022,0002,090,000
+100.0%
0.10%
RAD NewRITE AID CORP$2,002,000700,000
+100.0%
0.09%
GILD NewGILEAD SCIENCES INC$1,794,00035,000
+100.0%
0.08%
MSTX NewMAST THERAPEUTICS INC$1,695,0003,948,302
+100.0%
0.08%
CTRX NewCATAMARAN CORP$1,463,00030,000
+100.0%
0.07%
NewAUXILIUM PHARMACEUTICALS INCnote 1.500% 7/1$1,452,0001,500,000
+100.0%
0.07%
PTN NewPALATIN TECHNOLOGIES INC$1,240,0002,000,000
+100.0%
0.06%
IRWD NewIRONWOOD PHARMACEUTICALS INCput$993,000100,000
+100.0%
0.05%
BONE NewBACTERIN INTL HLDGS INC$866,0001,924,386
+100.0%
0.04%
GTIV NewGENTIVA HEALTH SERVICES INC$775,00077,839
+100.0%
0.04%
SLTM NewSOLTA MED INC$773,000339,063
+100.0%
0.04%
WCRX NewWARNER CHILCOTT PLC IRELAND$688,00034,543
+100.0%
0.03%
HOLX NewHOLOGIC INC$676,00035,000
+100.0%
0.03%
ILMN NewILLUMINA INC$629,0008,399
+100.0%
0.03%
MYGN NewMYRIAD GENETICS INC$505,00018,777
+100.0%
0.02%
QCOR NewQUESTCOR PHARMACEUTICALS INC$454,00010,000
+100.0%
0.02%
LHCG NewLHC GROUP INC$374,00019,087
+100.0%
0.02%
ECYT NewENDOCYTE INC$364,00027,708
+100.0%
0.02%
ALKS NewALKERMES PLC$315,00011,000
+100.0%
0.02%
AFAM NewALMOST FAMILY INC$252,00013,200
+100.0%
0.01%
SPPI NewSPECTRUM PHARMACEUTICALS INC$237,00031,750
+100.0%
0.01%
ICAD NewICAD INC$233,00038,887
+100.0%
0.01%
OREX NewOREXIGEN THERAPEUTICS INC$132,00022,575
+100.0%
0.01%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2013-08-14
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AERIE PHARMACEUTICALS INC36Q3 20223.6%
CENTENE CORP DEL30Q3 20233.0%
BIOCRYST PHARMACEUTICALS INC29Q3 20232.2%
MOLINA HEALTHCARE INC26Q3 20221.7%
EHEALTH INC25Q3 20202.0%
INTERCEPT PHARMACEUTICALS IN24Q1 20232.2%
MYLAN NV23Q3 20206.2%
PORTOLA PHARMACEUTICALS INC23Q1 20196.0%
BROOKDALE SR LIVING INC23Q3 20232.2%
ALIMERA SCIENCES INC23Q3 20190.8%

View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.

Latest significant ownerships (13-D/G)
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) Q2 2013 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
DA32 Life Science Tech Acquisition Corp.August 01, 20235,145,00091.1%
CareMax, Inc.March 13, 202318,691,42316.4%
CareMax, Inc.June 02, 202218,691,42320.7%

View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.

Latest filings
TypeFiled
32024-03-19
42024-03-19
42024-03-12
32024-03-08
42024-02-16
13F-HR2024-02-14
42024-02-08
32024-02-01
42023-11-21
13F-HR2023-11-14

View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (2121625000.0 != 2121628000.0)

Export DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s holdings